<DOC>
	<DOCNO>NCT02101606</DOCNO>
	<brief_summary>Rationale The proven therapy acute stroke tPA within 4.5 hour symptom onset . This standard care patient present hospital within time frame . Thrombolysis outside 4.5 hour window consider experimental compassionate ground . Tenecteplase ( TNK ) genetically modify variant tPA many theoretical advantage acute stroke . Studies show systemic plasminogen activation high tPA administration , relative TNK associate increase risk bleed event . Imaging cerebral blood flow ( CBF ) MRI ( perfusion weight imaging-PWI ) CT perfusion ( CTP ) perform routinely standard clinical scanner . Patients evidence large volume tissue low CBF , also structurally intact , demonstrate either normal signal Diffusion weight imaging ( DWI ) normal cerebral blood volume ( CBV ) consider penumbral pattern . Patients penumbral pattern appear ideal candidate thrombolytic therapy , regardless time onset . Study Hypotheses 1 . The primary aim study demonstrate feasibility safety TNK base thrombolysis ischemic stroke patient present 4.5-24 hour symptom onset . 2 . It hypothesize treatment TNK patient penumbral pattern associate reperfusion , early neurological improvement penumbral tissue salvage . Study Design The study plan open label feasibility safety study acute treatment TNK ischemic stroke patient penumbral pattern evident advance MRI CT perfusion sequence . Study Outcomes The primary outcome study safety endpoint , specifically frequency symptomatic hemorrhagic transformation evident MRI CT image 24 h day 5 scan . The ECASS II system rating hemorrhagic transformation apply GRE/SWI image Significance Current treatment paradigm permit success tPA extend beyond narrow limit therapeutic window 4.5 hour . Clearly , effective patient selection criterion require . Penumbral image biologically plausible , practical show predictive outcome . Application image technique acute stroke population promise strategy extend therapeutic window introduce superior thrombolytic agent .</brief_summary>
	<brief_title>Penumbral Based Novel Thrombolytic Therapy Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Tenecteplase</mesh_term>
	<mesh_term>Fibrinolytic Agents</mesh_term>
	<criteria>1 . Acute ischemic stroke patient , within 24 hour symptom onset . In case onset time establish , include symptom upon waking , consider time patient last know well . 2 . All patient 18 year old . 3 . Baseline NIHSS must 418 inclusive . 4 . Blood pressure ( BP ) must ≤180 mmHg systolic ≤105 mmHg diastolic time enrolment . Treatment high systolic BP permit , prior enrolment . 5 . Female patient childbearing potential negative pregnancy test prior enrollment . 6 . NCCT ASPECT score NCCT assess prior enrolment . An ASPECT score &gt; 6 required inclusion trial . Patients ASPECT score ≤6 consider screening failure image conduct . 7 . MRI Patients MR mismatch score &gt; 2 . This define minimum 3 ASPECTS region evidence hypoperfusion visible MTT map , associate normal diffusion demonstrate DWI . This ensure patient 20 % mismatch volume . In case PWI demonstrate oligemia ACA PCA territory , patient treat diffusion abnormality volumes 50 % MTT deficits visual inspection . 8 . CTP Patients CTP mismatch score &gt; 2 . This define minimum 3 ASPECTS region evidence hypoperfusion , visible MTT map , associate normal CBV . This ensure patient 20 % mismatch volume . Patients contraindication MRI CT perfusion exclude . MRI Patients metallic implant past sensitivity gadolinium contrast medium exclude MRI . Due recent report nephrogenic systemic fibrosis associate gadolinium exposure individual preexist renal failure , patient Creatinine &gt; 160 μmol/l Glomerular Filtration Rate ( GFR ) &lt; 60 ml/min also excluded.72 Patients metallic implant kind , pacemaker foreign body exclude MRI , excessive claustrophobia . CT Perfusion Patients past sensitivity iodinate contrast medium , serum creatinine &gt; 160 μmol/l Glomerular Filtration Rate ( GFR ) &lt; 50 ml/min exclude CT perfusion image . Patients take metformin eligible , metformin withhold 48 hour image avoid possible metabolic acidosis . Thrombolysis Patients suffer prior ischemic stroke within 30 day present event history intracranial hemorrhage exclude . Patients know secured unsecured cerebral aneurysm vascular malformation ineligible . An inability control systolic BP &gt; 180 mmHg , diastolic BP &gt; 105 mmHg IV antihypertensive medication result exclusion . Patients know coagulopathy evidence active bleeding exclude . Surgical procedure , biopsy , subclavian venous arterial puncture , trauma , gastrointestinal genitourinary bleeding within 14 day event result exclusion . Patients treat IV heparin within previous 24 hour abnormal PTT exclude , take oral anticoagulant , result INR &gt; 1.4 . A platelet count &lt; 100 000 , venous glucose either &lt; 3 mmol/l &gt; 18 mmol/l result exclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acute Stroke</keyword>
	<keyword>Cerebral Stroke</keyword>
	<keyword>Brain Ischemia</keyword>
	<keyword>Perfusion Imaging</keyword>
	<keyword>MRI , Diffusion Weighted</keyword>
	<keyword>MRI , Perfusion Weighted</keyword>
</DOC>